Literature DB >> 34790620

Bowel Perforation During Haemophagocytic Lymphohistiocytosis Treatment with Corticosteroids and Anakinra.

Jan Adamski1, Björn Jäschke2, Tuomas Nieminen3, Wojciech Weigl4.   

Abstract

We report the use of anakinra to treat a case of a 64-year-old man diagnosed with haemophagocytic lymphohistiocytosis (HLH) with neurological involvement. After the administration of intravenous pulse corticosteroid therapy, immunoglobulin and anakinra the patient showed neurological recovery. However, the recovery was complicated by the perforation of a pre-existing bowel diverticulum. The effect of anakinra on bowel inflammation has not yet been clearly established. It can potentially augment bowel inflammation and contribute to the risk of bowel perforation associated with the concomitant use of corticosteroids. LEARNING POINTS: Anakinra can potentially augment bowel inflammation.The concomitant use of anakinra and corticosteroids may increase the risk of bowel perforation.Use of anakinra and corticosteroids in patients with pre-existing gastrointestinal diseases requires vigilant observation for abdominal symptoms. © EFIM 2021.

Entities:  

Keywords:  Diverticulitis; gastrointestinal diseases; gut; haemophagocytic lymphohistiocytosis (HLH); interkeukin-1 (IL-1) receptor antagonist

Year:  2021        PMID: 34790620      PMCID: PMC8592665          DOI: 10.12890/2021_002842

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  12 in total

1.  Crohn disease worsened by anakinra administration.

Authors:  John D Carter; Joanne Valeriano; Frank B Vasey
Journal:  J Clin Rheumatol       Date:  2003-08       Impact factor: 3.517

2.  Nonoperative management of perforated acute diverticulitis with extraluminal air: results and risk factors of failure.

Authors:  Alberto Titos-García; Jose M Aranda-Narváez; Laura Romacho-López; Antonio J González-Sánchez; Isaac Cabrera-Serna; Julio Santoyo-Santoyo
Journal:  Int J Colorectal Dis       Date:  2017-07-17       Impact factor: 2.571

3.  Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.

Authors:  Paul La Rosée; AnnaCarin Horne; Melissa Hines; Tatiana von Bahr Greenwood; Rafal Machowicz; Nancy Berliner; Sebastian Birndt; Juana Gil-Herrera; Michael Girschikofsky; Michael B Jordan; Ashish Kumar; Jan A M van Laar; Gunnar Lachmann; Kim E Nichols; Athimalaipet V Ramanan; Yini Wang; Zhao Wang; Gritta Janka; Jan-Inge Henter
Journal:  Blood       Date:  2019-04-16       Impact factor: 22.113

Review 4.  Increased diverticular complications with nonsteriodal anti-inflammatory drugs and other medications: a systematic review and meta-analysis.

Authors:  C L Kvasnovsky; S Papagrigoriadis; I Bjarnason
Journal:  Colorectal Dis       Date:  2014-06       Impact factor: 3.788

Review 5.  Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for Clinicians.

Authors:  Aprajita Jagpal; Jeffrey R Curtis
Journal:  Drug Saf       Date:  2018-06       Impact factor: 5.606

Review 6.  Medical influences, surgical outcomes: role of common medications on the risk of perforation from untreated diverticular disease.

Authors:  Gianpiero Gravante; Shuker Yahia
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

Review 7.  Cytokines and mucosal immunity.

Authors:  Giorgos Bamias; Kristen O Arseneau; Fabio Cominelli
Journal:  Curr Opin Gastroenterol       Date:  2014-11       Impact factor: 3.287

Review 8.  Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition.

Authors:  Henk M W Verheul; Herbert M Pinedo
Journal:  Nat Rev Cancer       Date:  2007-06       Impact factor: 60.716

9.  Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis.

Authors:  Boris Hügle; Fabian Speth; Johannes-Peter Haas
Journal:  Pediatr Rheumatol Online J       Date:  2017-03-14       Impact factor: 3.054

Review 10.  Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome.

Authors:  Puja Mehta; Randy Q Cron; James Hartwell; Jessica J Manson; Rachel S Tattersall
Journal:  Lancet Rheumatol       Date:  2020-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.